Aqueous-Deficient Dry Eye
Aqueous-deficient dry eye is the less common of the two main subtypes of dry eye disease — but often the more severe. While evaporative dry eye accounts for roughly 80 percent of chronic dry eye cases, aqueous-deficient dry eye involves the lacrimal glands directly: they are not producing enough of the watery component of tears. According to the TFOS DEWS II Definition and Classification Report, aqueous-deficient dry eye is most commonly driven by autoimmune disease, age-related gland decline, or systemic medications. Dr. Y. Shira Kresch evaluates and treats aqueous-deficient dry eye at our Southfield, MI clinic.
If your eyes feel constantly dry, your tear production is measurably reduced on testing, and standard treatments for evaporative dry eye have not helped — you may have aqueous-deficient dry eye. The condition has different underlying mechanisms and requires different treatment than the more common evaporative form.
What Is Aqueous-Deficient Dry Eye?
A healthy tear film has three components — a mucin layer that adheres to the eye, an aqueous (watery) middle layer that provides moisture and nutrients, and a lipid (oily) outer layer that prevents evaporation. In aqueous-deficient dry eye, the middle layer is the problem: the lacrimal glands that produce the watery component are not producing enough.
The TFOS DEWS II classification divides dry eye into two main subtypes — evaporative and aqueous-deficient. Most patients have one dominant subtype, though many have features of both (mixed dry eye). Identifying which subtype is dominant is critical because the treatments are different.
What Causes Aqueous-Deficient Dry Eye?
Autoimmune Disease
Autoimmune diseases — particularly Sjögren syndrome, rheumatoid arthritis, and lupus — are the most common cause of severe aqueous-deficient dry eye. The immune system attacks the lacrimal glands, progressively destroying the cells that produce tears. According to the American Academy of Ophthalmology, all patients with unexplained severe aqueous deficiency should be evaluated for Sjögren syndrome.
Age-Related Lacrimal Gland Decline
Tear production naturally declines with age, particularly after 65. The lacrimal glands lose functional tissue gradually over decades, and many patients reach a threshold of clinical symptoms in their 70s or 80s.
Medications
Many medications reduce tear production through anticholinergic effects on the lacrimal glands. The most significant offenders include antihistamines, antidepressants, antimuscarinics for overactive bladder, beta-blockers, and certain blood pressure medications.
Hormonal Changes
The lacrimal glands are hormonally regulated. Menopause, particularly the decline in androgens that accompanies it, contributes significantly to aqueous-deficient dry eye in women.
Lacrimal Gland Damage
Previous radiation therapy to the head and neck region, certain types of chemotherapy, and direct surgical or traumatic injury to the lacrimal glands can all cause reduced tear production.
Ocular Surface Disease (Secondary Causes)
Chronic ocular surface inflammation from any cause — including untreated Meibomian Gland Dysfunction — can secondarily reduce tear production through neural feedback mechanisms.
Symptoms of Aqueous-Deficient Dry Eye
- Constant feeling of dryness or grittiness, often worse than evaporative dry eye
- Burning or stinging sensation throughout the day
- Eyes that look red and feel irritated
- Difficulty producing tears even when emotionally moved
- Stringy mucus in or around the eye
- Persistent foreign-body sensation
- Eye fatigue, especially with reading or screen use
- Light sensitivity
- Blurred or fluctuating vision
- Concurrent dry mouth (suggestive of Sjögren syndrome)
Unlike evaporative dry eye where reflex tearing is common, patients with pure aqueous-deficient dry eye often have noticeably reduced ability to produce tears at all — even emotional tears may be diminished.
How We Diagnose Aqueous-Deficient Dry Eye
The most important diagnostic test for aqueous deficiency is the Schirmer test — a small strip of filter paper is placed at the edge of the lower eyelid to measure how much aqueous tear is produced in 5 minutes. Significantly reduced values strongly suggest aqueous deficiency.
At your comprehensive dry eye evaluation, Dr. Kresch also uses:
- Schirmer test (with and without anesthesia) — measures aqueous tear production
- Tear meniscus height — visualizes the volume of tears resting at the eyelid margin
- Tear osmolarity — typically elevated in aqueous-deficient dry eye
- Ocular surface staining — shows characteristic patterns of damage in severe cases
- Meibography — assesses whether evaporative dry eye is also present (mixed dry eye)
- Lid margin examination — to identify concurrent anterior blepharitis or Demodex
- Laboratory workup referral — when Sjögren or other autoimmune disease is suspected, we coordinate with primary care or rheumatology
How We Treat Aqueous-Deficient Dry Eye
Punctal Plugs
Punctal plugs are tiny inserts placed in the tear drainage ducts to conserve the limited tears the lacrimal glands are still producing. They are typically among the first interventions for aqueous-deficient dry eye because they amplify the effect of whatever tear production remains.
Anti-Inflammatory Therapy
Prescription anti-inflammatory and immunomodulator drops — cyclosporine (Restasis), lifitegrast (Xiidra), and short courses of corticosteroids during flares — address the chronic ocular surface inflammation that accompanies and perpetuates aqueous deficiency. According to AllAboutVision, these medications work by reducing the inflammatory cascade rather than simply lubricating the surface.
Autologous Serum Tears
For moderate-to-severe cases, drops compounded from a patient’s own blood serum provide growth factors and proteins that promote ocular surface healing. Serum tears are particularly valuable for patients with poor corneal healing.
Scleral Lenses
For severe aqueous-deficient dry eye that has not responded to other approaches, scleral lenses can be transformative. The continuous saline reservoir behind the lens provides constant corneal hydration that no eye drop can match — particularly important for patients whose lacrimal glands cannot produce sufficient tears regardless of other interventions.
Treatment of Concurrent Conditions
Many patients with aqueous-deficient dry eye also have Meibomian Gland Dysfunction (mixed dry eye). Addressing both subtypes simultaneously — through the combined treatment protocol where appropriate — produces better outcomes than addressing either alone.
Systemic Disease Coordination
For autoimmune-driven aqueous deficiency, coordinated care with rheumatology is critical. Optimizing systemic immunosuppression helps preserve remaining lacrimal gland function. We routinely communicate with referring rheumatologists.
Aqueous-Deficient vs Evaporative: Why It Matters
The distinction between these two subtypes drives treatment selection:
- Evaporative dry eye (the more common type) responds best to treatments addressing Meibomian Gland Dysfunction — IPL, RF, LLLT, manual gland expression
- Aqueous-deficient dry eye responds best to interventions that conserve tears, reduce inflammation, and protect the surface — punctal plugs, anti-inflammatory drops, serum tears, scleral lenses
Treating aqueous-deficient dry eye with evaporative protocols (or vice versa) explains why so many patients fail to improve under general optometry care. Proper subtype identification through a comprehensive evaluation is the foundation of effective treatment.
Aqueous-deficient dry eye — when the eyes simply do not make enough tears — can be among the hardest to keep comfortable. For severe cases, a specialty lens holds a reservoir of fluid against the eye all day. Our affiliated practice Michigan Contact Lens fits scleral lenses for exactly this kind of severe, tear-deficient dry eye. Dr. Kresch sees patients at both practices.
Frequently Asked Questions
Q: How do I know if I have aqueous-deficient or evaporative dry eye? A proper diagnostic evaluation can distinguish them. Aqueous-deficient is characterized by low Schirmer values and reduced tear production; evaporative by rapid tear breakup time and Meibomian gland changes. Many patients have both (mixed dry eye).
Q: Could my aqueous-deficient dry eye be Sjögren syndrome? Possibly. Sjögren is the most common autoimmune cause of severe aqueous deficiency. If you have concurrent dry mouth, joint symptoms, or family history of autoimmune disease, evaluation for Sjögren is appropriate. See our autoimmune dry eye page for more.
Q: Can aqueous-deficient dry eye be cured? Generally no — it is a chronic condition that requires ongoing management. However, with proper treatment most patients can achieve substantial symptom relief and prevent progression to more severe disease.
Q: Will artificial tears be enough? For mild cases sometimes. For moderate-to-severe aqueous-deficient dry eye, artificial tears help symptomatically but do not address the underlying problem. Prescription therapy, punctal plugs, and often scleral lenses are needed for lasting improvement.
Q: Are scleral lenses worth considering for me? If you have moderate-to-severe aqueous-deficient dry eye and standard treatments have not produced satisfactory results, scleral lenses are often life-changing. A consultation can determine whether they are appropriate for your specific case.
Q: Will insurance cover treatment? The diagnostic evaluation is typically covered by medical insurance. Prescription drops are typically covered. Punctal plugs are often covered. Scleral lenses prescribed for documented medical conditions are sometimes covered by medical insurance (not vision insurance). We help with insurance coordination.
Q: Are there any treatments to restore lacrimal gland function? Currently no — lost lacrimal gland tissue cannot be regenerated. This is why early diagnosis and treatment matter: protecting remaining function is much easier than trying to recover lost function.